argenx SE reported $539M in EBITDA for its fiscal quarter ending in September of 2026.





Ebitda Change Date
AstraZeneca USD 7.46B 2.3B Sep/2026
Genmab DKK 401M 186M Jun/2026
GlaxoSmithKline GBP 3.51B 734M Jun/2026
GRIFOLS EUR 505M 32M Sep/2026
Hikma Pharmaceutical USD 369M 84M Dec/2024
Lakefront Biotherapeutics EUR -63.7M 624.2M Mar/2026
Qiagen NV USD 219.78M 12.13M Sep/2026
UCB EUR 1.6B 570M Dec/2025